Cargando…
Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection
PURPOSE: The aim of the present study was to investigate the immune response induced by Mycobacterium marinum infection in vitro and the potential of M. marinum as an immunotherapy for M. tuberculosis infection. METHODS: The potential human immune response to certain bacillus infections was investig...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733875/ https://www.ncbi.nlm.nih.gov/pubmed/23930073 http://dx.doi.org/10.2147/DDDT.S45197 |
_version_ | 1782279422536056832 |
---|---|
author | Tian, Wei-wei Wang, Qian-qiu Liu, Wei-da Shen, Jian-ping Wang, Hong-sheng |
author_facet | Tian, Wei-wei Wang, Qian-qiu Liu, Wei-da Shen, Jian-ping Wang, Hong-sheng |
author_sort | Tian, Wei-wei |
collection | PubMed |
description | PURPOSE: The aim of the present study was to investigate the immune response induced by Mycobacterium marinum infection in vitro and the potential of M. marinum as an immunotherapy for M. tuberculosis infection. METHODS: The potential human immune response to certain bacillus infections was investigated in an immune cell-bacillus coculture system in vitro. As a potential novel immunotherapy, M. marinum was studied and compared with two other bacilli, Bacillus Calmette-Guérin (BCG) and live attenuated M. tuberculosis. We examined the changes in both the bacilli and immune cells, especially the time course of the viability of mycobacteria in the coculture system and host immune responses including multinuclear giant cell formation by Wright-Giemsa modified staining, macrophage polarization by cell surface antigen expression, and cytokines/chemokine production by both mRNA expression and protein secretion. RESULTS: The M. marinum stimulated coculture group showed more expression of CD209, CD68, CD80, and CD86 than the BCG and M. tuberculosis (an attenuated strain, H37Ra) groups, although the differences were not statistically significant. Moreover, the M. marinum group expressed more interleukin (IL)-1B and IL-12p40 on day 3 (IL-1B: P = 0.003 and 0.004, respectively; IL-12p40: P = 0.001 and 0.011, respectively), a higher level of CXCL10 on day 1 (P = 0.006 and 0.026, respectively), and higher levels of chemokine (C-X-C motif) ligand (CXCL) 8 and chemokine (C motif) ligand (XCL) 1 on day 3 (CXCL8: P = 0.012 and 0.014, respectively; XCL1: P = 0.000 and 0.000, respectively). The M. marinum stimulated coculture group also secreted more tumor necrosis factor (TNF)-α, IL-1β, and IL-10 on day 1 (TNF-α: P = 0.000 and 0.000, respectively; IL-1β: P = 0.000 and 0.000, respectively; IL-10: P = 0.002 and 0.019, respectively) and day 3 (TNF-α: P = 0.000 and 0.000, respectively; IL-1β: P = 0.000 and 0.001, respectively; IL-10: P = 0.000 and 0.000, respectively). In addition, the colony-forming units (an index of viability) of M. marinum in the M. marinum stimulated coculture group was significantly less than that of BCG and H37Ra in their corresponding bacillus stimulated groups (P = 0.037 and 0.013, respectively). CONCLUSION: Our results indicated that M. marinum could be a potentially safe and effective immunotherapy. |
format | Online Article Text |
id | pubmed-3733875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-37338752013-08-08 Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection Tian, Wei-wei Wang, Qian-qiu Liu, Wei-da Shen, Jian-ping Wang, Hong-sheng Drug Des Devel Ther Original Research PURPOSE: The aim of the present study was to investigate the immune response induced by Mycobacterium marinum infection in vitro and the potential of M. marinum as an immunotherapy for M. tuberculosis infection. METHODS: The potential human immune response to certain bacillus infections was investigated in an immune cell-bacillus coculture system in vitro. As a potential novel immunotherapy, M. marinum was studied and compared with two other bacilli, Bacillus Calmette-Guérin (BCG) and live attenuated M. tuberculosis. We examined the changes in both the bacilli and immune cells, especially the time course of the viability of mycobacteria in the coculture system and host immune responses including multinuclear giant cell formation by Wright-Giemsa modified staining, macrophage polarization by cell surface antigen expression, and cytokines/chemokine production by both mRNA expression and protein secretion. RESULTS: The M. marinum stimulated coculture group showed more expression of CD209, CD68, CD80, and CD86 than the BCG and M. tuberculosis (an attenuated strain, H37Ra) groups, although the differences were not statistically significant. Moreover, the M. marinum group expressed more interleukin (IL)-1B and IL-12p40 on day 3 (IL-1B: P = 0.003 and 0.004, respectively; IL-12p40: P = 0.001 and 0.011, respectively), a higher level of CXCL10 on day 1 (P = 0.006 and 0.026, respectively), and higher levels of chemokine (C-X-C motif) ligand (CXCL) 8 and chemokine (C motif) ligand (XCL) 1 on day 3 (CXCL8: P = 0.012 and 0.014, respectively; XCL1: P = 0.000 and 0.000, respectively). The M. marinum stimulated coculture group also secreted more tumor necrosis factor (TNF)-α, IL-1β, and IL-10 on day 1 (TNF-α: P = 0.000 and 0.000, respectively; IL-1β: P = 0.000 and 0.000, respectively; IL-10: P = 0.002 and 0.019, respectively) and day 3 (TNF-α: P = 0.000 and 0.000, respectively; IL-1β: P = 0.000 and 0.001, respectively; IL-10: P = 0.000 and 0.000, respectively). In addition, the colony-forming units (an index of viability) of M. marinum in the M. marinum stimulated coculture group was significantly less than that of BCG and H37Ra in their corresponding bacillus stimulated groups (P = 0.037 and 0.013, respectively). CONCLUSION: Our results indicated that M. marinum could be a potentially safe and effective immunotherapy. Dove Medical Press 2013-07-29 /pmc/articles/PMC3733875/ /pubmed/23930073 http://dx.doi.org/10.2147/DDDT.S45197 Text en © 2013 Tian et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Tian, Wei-wei Wang, Qian-qiu Liu, Wei-da Shen, Jian-ping Wang, Hong-sheng Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection |
title | Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection |
title_full | Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection |
title_fullStr | Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection |
title_full_unstemmed | Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection |
title_short | Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection |
title_sort | mycobacterium marinum: a potential immunotherapy for mycobacterium tuberculosis infection |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733875/ https://www.ncbi.nlm.nih.gov/pubmed/23930073 http://dx.doi.org/10.2147/DDDT.S45197 |
work_keys_str_mv | AT tianweiwei mycobacteriummarinumapotentialimmunotherapyformycobacteriumtuberculosisinfection AT wangqianqiu mycobacteriummarinumapotentialimmunotherapyformycobacteriumtuberculosisinfection AT liuweida mycobacteriummarinumapotentialimmunotherapyformycobacteriumtuberculosisinfection AT shenjianping mycobacteriummarinumapotentialimmunotherapyformycobacteriumtuberculosisinfection AT wanghongsheng mycobacteriummarinumapotentialimmunotherapyformycobacteriumtuberculosisinfection |